Verus Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$413K Hold
344
0.34% 40
2026
Q1
$316K Buy
344
+1
+0.3% +$1.01K 0.29% 43
2025
Q4
$369K Buy
343
+11
+3% +$10.5K 0.34% 42
2025
Q3
$253K Sell
332
-20
-6% -$14.9K 0.24% 53
2025
Q2
$274K Buy
352
+5
+1% +$3.88K 0.28% 49
2025
Q1
$287K Hold
347
0.31% 43
2024
Q4
$268K Buy
+347
New +$287K 0.3% 45

Other funds holding LLY

Verus Wealth Management's LLY Position: Q2 2026 in Review

Verus Wealth Management held its Eli Lilly (LLY) position steady in Q2 2026 at 344 shares worth $413K. The position accounts for 0.34% of the portfolio, ranked #40.

Verus Wealth Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Verus Wealth Management held 344 shares of Eli Lilly worth $413K as of Q2 2026.
  • Verus Wealth Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.34% of Verus Wealth Management's portfolio in Q2 2026, its #40 holding.
  • Verus Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Verus Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.